Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
1.890
+0.080 (4.42%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Elicio Therapeutics Employees
Elicio Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year. That makes Elicio Therapeutics the 36,684th largest employer in the world and 5,077th in the United States.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
n/a
Profits / Employee
-$1,146,697
Market Cap
49.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | 1 | 3.13% |
| Dec 31, 2024 | 32 | 0 | - |
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Caribou Biosciences | 97 |
| eXoZymes | 32 |
| ImageneBio | 18 |
| Edesa Biotech | 17 |
| CervoMed | 15 |
| Apollomics | 14 |
| Werewolf Therapeutics | 14 |
ELTX News
- 21 hours ago - Elicio Therapeutics Proxy statement: Proxy filing - Filings
- 15 days ago - Elicio Therapeutics price target lowered to $8 from $27 at B. Riley - TheFly
- 15 days ago - Elicio Therapeutics announces Phase 2 AMPLIFY-7P data selected for ESMO ’26 - TheFly
- 15 days ago - Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026 - GlobeNewsWire
- 25 days ago - Elicio Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - Elicio Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - Elicio Therapeutics Slides: Corporate presentation - Filings